{"name":"RSPR Pharma AB","slug":"rspr-pharma-ab","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"CRD007","genericName":"CRD007","slug":"crd007","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"CRD007","genericName":"CRD007","slug":"crd007","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxNbXVNdGxoNzBJX1R2NTBNR083WTlUbXRTMVJ2M2FBQzRSNXpWVGdqUndQWTVDME1KRzR5ZEJjcy1DX01lc3E3NW5BMGJZWUYwbWNkcVlOdUM3UHFjWlFhTzV0MHgwdmxOakcwMmpVcHBVb1YtWXZscVgtenN3WHBNREVfRjdzanBsNFZGLUhrTkllTmItVWVTaFM0WDRoLUs4TnZyMGRKUG1waUxRRVJ6LTVB?oc=5","date":"2019-11-26","type":"pipeline","source":"European Medical Journal","summary":"Epithelial Barrier Dysfunction in Type 2 Inflammatory Diseases - European Medical Journal","headline":"Epithelial Barrier Dysfunction in Type 2 Inflammatory Diseases","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxOWEdCOHB5d1hZNmhRVzFGMlFtbUtaWnpYTVV4WkZFZkl3V2RTMEhBUkhuRm5MZzRwTXRZdXN3Q3hXeW91UXFIMXpHT0Z4TVlXQmRoRDEyRmlVNVFra2xVa1YxNFl2bnZxcWxIY2pGa0hzb29aeU1fOHZlc0FjM0tWQXUxS1JyMm5wX1NtaEFoV0MxUURMenpWVzJuZUtwY2NyLWp4akpBT2gzZFVoeWs2NFVoVGJYRmZfUWtfS2hLcDl1RjNLZFkw?oc=5","date":"2018-12-13","type":"pipeline","source":"European Medical Journal","summary":"Type 2 Inflammation and the Evolving Profile of Uncontrolled Persistent Asthma - European Medical Journal","headline":"Type 2 Inflammation and the Evolving Profile of Uncontrolled Persistent Asthma","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}